Evaluation of the Pharmacokinetic Drug-Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers

• Váldodahkkit: Hae Won Lee (Dahkki), Woo Youl Kang (Dahkki), Wookjae Jung (Dahkki), Mi-Ri Gwon (Dahkki), Kyunghee Cho (Dahkki), Dong Heon Yang (Dahkki), Young-Ran Yoon (Dahkki), Sook Jin Seong (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2020-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Dyslipidemia is a major risk factor for development of atherosclerosis and cardiovascular disease (CVD). Effective lipid-lowering therapies has led to CVD risk reduction. This study evaluated the possible pharmacokinetic interactions between fenofibrate, a peroxisome proliferators-activated receptor...